211 related articles for article (PubMed ID: 11826832)
1. [2 year follow-up of 321 patients with an implantable cardioverter/defibrillator: comparison of patients with and without atrial fibrillation].
Ryan S; Siemon G; Drögemüller A; Rameken M; Vater M; Senges J; Seidl K
Z Kardiol; 2001 Dec; 90(12):906-15. PubMed ID: 11826832
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
[TBL] [Abstract][Full Text] [Related]
3. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
[TBL] [Abstract][Full Text] [Related]
4. Dual chamber implantable cardioverter defibrillator benefits and limitations.
Fan K; Lee K; Lau CP
J Interv Card Electrophysiol; 1999 Oct; 3(3):239-45. PubMed ID: 10490480
[TBL] [Abstract][Full Text] [Related]
5. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
[TBL] [Abstract][Full Text] [Related]
6. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
8. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
[TBL] [Abstract][Full Text] [Related]
9. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
10. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
Proclemer A; Della Bella P; Facchin D; Fattore L; Carbucicchio C; Tondo C; Lunati M; Vecchi MR; Petz E; Zecchin M
Europace; 2001 Apr; 3(2):132-5. PubMed ID: 11333050
[TBL] [Abstract][Full Text] [Related]
11. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
12. Digitalis Therapy and Risk of Recurrent Ventricular Tachyarrhythmias and ICD Therapies in Atrial Fibrillation and Heart Failure.
Schupp T; Behnes M; Weiss C; Nienaber C; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Rusnak J; Weidner K; Akin M; Mashayekhi K; Borggrefe M; Akin I
Cardiology; 2019; 142(3):129-140. PubMed ID: 31189160
[TBL] [Abstract][Full Text] [Related]
13. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
14. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356
[TBL] [Abstract][Full Text] [Related]
15. [Optimized programming of sustained rate duration in patients with implantable cardioverter-defibrillators and diagnosed atrial fibrillation].
Wieckhorst A; Buchwald AB; Unterberg C
Z Kardiol; 1999 Jun; 88(6):426-33. PubMed ID: 10441813
[TBL] [Abstract][Full Text] [Related]
16. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
[TBL] [Abstract][Full Text] [Related]
17. Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.
Gasparini M; Lunati MG; Proclemer A; Arenal A; Kloppe A; Martínez Ferrer JB; Hersi AS; Gulaj M; Wijffels MCE; Santi E; Manotta L; Varma N
JACC Clin Electrophysiol; 2017 Nov; 3(11):1275-1282. PubMed ID: 29759624
[TBL] [Abstract][Full Text] [Related]
18. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study.
Grönefeld GC; Mauss O; Li YG; Klingenheben T; Hohnloser SH
J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1208-14. PubMed ID: 11083241
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction.
Lehmann HI; Goette A; Martens-Lobenhoffer J; Hammwöhner M; Röhl FW; Bukowska A; Ghanem A; Klein HU; Bode-Böger SM
Europace; 2011 Oct; 13(10):1428-35. PubMed ID: 21752828
[TBL] [Abstract][Full Text] [Related]
20. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
Schoels W; Swerdlow CD; Jung W; Stein KM; Seidl K; Haffajee CJ;
J Cardiovasc Electrophysiol; 2001 May; 12(5):521-8. PubMed ID: 11386511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
